VetMedGuide

Vet Med Guide

Pharmaceuticals2026-05-15 · 8 min read

Cerenia for Dogs: What Maropitant Treats, How Dosing Works

A label-first guide to Cerenia (maropitant) for dogs: dosing by age and indication, off-label uses, and when anti-nausea medication can delay needed care.

Ran Chen
Ran Chen
Founder, VetMedGuide. Life-sciences operator and 10× global market-access lead.
Published

Cerenia (maropitant citrate) is the only FDA-approved oral anti-nausea medication specifically developed for dogs. Manufactured by Zoetis, it blocks the neurokinin-1 (NK-1) receptor — the binding site for substance P, a neurotransmitter that triggers the vomiting reflex in the brain's vomit center and chemoreceptor trigger zone.

This article covers what the label approves, how dosing differs between acute vomiting and motion sickness, the off-label uses veterinarians commonly discuss, and the situations where giving an antiemetic without a workup can be dangerous.

What Cerenia is approved for

The FDA label for Cerenia tablets covers two distinct indications in dogs:

  • Prevention of acute vomiting. Approved for dogs 8 weeks (2 months) and older. For puppies 2–7 months old, the label allows use for up to 5 consecutive days. For dogs 7 months and older, the label was updated in 2015 to allow use "as long as needed" — no fixed duration cap.
  • Prevention of vomiting due to motion sickness. Approved for dogs 4 months and older. The label allows use for up to 2 consecutive days.

The injectable formulation of Cerenia is FDA-approved for both dogs and cats (16 weeks and older) for the relief of acute vomiting. Generic injectable maropitant (Emeprev) is also approved. However, the tablets are labeled only for dogs; tablet use in cats is off-label, though widely practiced.

How maropitant works

Substance P binds to NK-1 receptors in the vomit center and the chemoreceptor trigger zone (CRTZ). Maropitant mimics the structure of substance P and occupies those receptors, preventing the real neurotransmitter from binding. The result is that the vomit center becomes extremely difficult to stimulate.

Because substance P is also involved in inflammation and pain signaling beyond nausea, maropitant has drawn research interest for uses beyond vomiting — including cough suppression, visceral pain modulation, and inflammatory conditions in cats. These uses are off-label and not reflected in the FDA label.

Cerenia takes effect within 1–2 hours. Its duration of action is approximately 24 hours, which supports once-daily dosing. It is non-sedating — unlike diphenhydramine (Benadryl) or meclizine (Dramamine), which are sometimes used for motion sickness in people but are not FDA-approved for vomiting in dogs and commonly cause drowsiness.

Dosing: acute vomiting vs motion sickness

The dose depends on the indication, and the difference is substantial.

Acute vomiting

  • Dose: 2 mg/kg body weight (approximately 0.9 mg/lb) once daily.
  • Age minimum: 8 weeks (2 months).
  • Duration: Up to 5 days for puppies 2–7 months; no fixed cap for dogs 7 months and older.
  • Tablet strengths: 16 mg, 24 mg, 60 mg, 160 mg (all scored).

Dogs that are actively vomiting may be started on the injectable formulation (1 mg/kg SC or IV) and then transitioned to tablets once vomiting is controlled. The tablets and injectable can be used interchangeably for once-daily dosing of acute vomiting.

Motion sickness

  • Dose: 8 mg/kg body weight (approximately 3.6 mg/lb) once daily — four times the acute vomiting dose.
  • Age minimum: 4 months (16 weeks).
  • Duration: Up to 2 consecutive days.
  • Administration timing: Give the tablet with a small amount of food at least 2 hours before travel. Do not give a full meal before travel. If the dog vomits the dose, do not redose.

The motion sickness dose is higher because the vestibular system (inner ear motion sensing) is a different vomiting pathway, and a higher plasma concentration of maropitant is needed to suppress it. A field study found that 93% of dogs prone to motion sickness did not vomit during a one-hour car ride when treated with Cerenia, compared to 48% given placebo.

Off-label uses veterinarians may discuss

The label is narrow, but veterinary medicine routinely uses maropitant beyond the labeled indications when the evidence supports it and the veterinarian judges it appropriate for the individual patient.

Chronic nausea and vomiting

Dogs with chronic conditions — chronic kidney disease, inflammatory bowel disease, pancreatitis — may receive maropitant long-term to control persistent nausea and maintain appetite. The 2015 label update removing the duration cap for dogs 7 months and older supports this use, though the specific condition being treated may not be on the label.

Cough suppression

Maropitant has demonstrated anti-tussive (cough-suppressing) properties in clinical practice. Some veterinarians prescribe it for dogs with collapsing trachea or chronic bronchitis, particularly when cough is stimulated by airway inflammation involving substance P pathways. This use is off-label.

Perioperative nausea

Injectable maropitant is commonly given before anesthesia to reduce vomiting associated with opioid premedications (morphine, hydromorphone) and to provide visceral pain relief as an adjunct to the primary analgesic plan.

The label notes that Cerenia is most effective in preventing acute vomiting associated with chemotherapy when administered prior to the chemotherapeutic agent. This is an increasingly common use in veterinary oncology.

Use in cats

Although Cerenia tablets are not labeled for cats, veterinarians routinely prescribe them off-label for feline vomiting, CKD-associated nausea, and pancreatitis. The typical dose is 1 mg/kg orally once daily. Long-term use in cats with chronic kidney disease has been studied and appears well tolerated, though the label carries a caution for hepatic disease, and doses are often reduced by 25–50% in cats with liver dysfunction.

Side effects

Side effects are uncommon. The most frequently reported are:

  • Vomiting the tablet shortly after administration. This is the most commonly noted side effect. Giving the tablet with a small amount of food can help. For the motion sickness dose, the label explicitly recommends giving it with a small amount of food to reduce stomach upset.
  • Hypersalivation (drooling). More common at the higher motion sickness dose.
  • Decreased appetite (anorexia). Reported in post-approval data.
  • Lethargy or depression. Reported in post-approval data.
  • Diarrhea. Less common.

The injectable formulation causes pain or vocalization on injection in roughly one-third of cats. Refrigerating the injection before administration can reduce the sting. This reaction is also seen in some dogs but is reported less frequently.

When Cerenia is not the right answer

The label carries important cautions:

  • Gastrointestinal obstruction. Safe use has not been evaluated in dogs with GI obstruction. Giving an antiemetic to a dog with an obstruction can mask progressive clinical signs and delay surgery.
  • Toxin ingestion. Safe use has not been evaluated in dogs that have ingested toxins. Vomiting is a protective mechanism when a dog has eaten something dangerous. Stopping the vomit reflex without addressing the underlying toxin can worsen the outcome.
  • Hepatic dysfunction. Use with caution in dogs with liver disease. Maropitant is metabolized by the liver, and impaired hepatic function can alter drug clearance.

In practice, these cautions mean that a dog presenting with acute vomiting usually needs a diagnostic workup before or alongside anti-nausea medication. Cerenia controls the symptom — it does not identify or treat the cause. If vomiting persists despite treatment, the label explicitly states the case should be re-evaluated.

What to ask your veterinarian

  • Why is my dog vomiting? Before starting Cerenia, the veterinarian should have a working diagnosis or at least a plan to rule out obstruction, toxin exposure, and systemic disease.
  • Which dose is my dog getting? The motion sickness dose (8 mg/kg) is four times the acute vomiting dose (2 mg/kg). The strength and number of tablets should match the intended use.
  • How long should my dog take this? For acute vomiting in dogs over 7 months, the label allows ongoing use, but the underlying cause should be investigated. For motion sickness, the cap is 2 consecutive days.
  • What signs should I watch for? Know when vomiting improves versus when it warrants a recheck. Persistent vomiting, abdominal pain, lethargy, or refusal to drink water are reasons to return to the clinic sooner than scheduled.
  • Are there drug interactions? Maropitant is metabolized by the liver (CYP pathway), so it may interact with other hepatically metabolized drugs. Tell your veterinarian about all medications and supplements your dog is taking.

Sources

Topics
Gastroenterology
Related Articles